Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005106 · ClinicalTrials.gov registry record · Phase 4
A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients
A Phase 4 study of HIV Infections, sponsored by Glaxo Wellcome.
- Completed
- Registry status
- Phase 4
- Development phase
- 230
- Enrollment target
- 20
- Study locations
NCT00005106: Completed Phase 4 study of HIV Infections, sponsored by Glaxo Wellcome.
NCT00005106 is a Phase 4 study of HIV Infections that has completed, run by Glaxo Wellcome. The registered enrollment target is 230 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (48% lower). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005106, a Phase 4 study of HIV Infections, has completed, sponsored by Glaxo Wellcome.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 230 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to look at the effects of different anti-HIV drug combinations on body fat changes in HIV-positive patients who have never received anti-HIV therapy before.
Conditions Studied
Interventions
- DRUG Lamivudine
- DRUG Stavudine
- DRUG Nelfinavir mesylate
- DRUG Lamivudine/Zidovudine
- DRUG Abacavir sulfate
Study Locations (20)
Florida
- IDC Research Initiative - Altamonte Springs
- Children's Diagnostic Treatment Ctr - Fort Lauderdale
- Community Health Care - Fort Lauderdale
- Comprehensive Care Center - Fort Lauderdale
- Univ of Miami School of Medicine - Miami
- South Shore Hosp - Miami
- Orange County Health Dept - Orlando
- Immunity Care and Research Inc - Plantation
- Daniel Seekins - Tampa
California
- Longbeach Memorial Med Ctr - Longbeach
- Good Samaritan Hosp - Los Angeles
- THE Clinic - Los Angeles
- AIDS Healthcare Foundation - Los Angeles
- Maxine Liggins - Los Angeles
- UCLA Care Ctr - Los Angeles
- Highland Gen Hosp / San Francisco Gen Hosp - Oakland
- San Francisco Gen Hosp - San Francisco
Alabama
- Univ of Alabama at Birmingham - Birmingham
Arizona
- Arizona Clinical Research Ctr Inc - Tucson
District of Columbia
- Georgetown Univ Med Ctr - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 1999-09 |
| Phase | Phase 4 |
What the finished NCT00005106 record still lists
NCT00005106 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (48% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 5 interventions - of which Lamivudine is the first listed.
NCT00005106 names 20 study sites across 5 states, led by Florida, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT00005106 about?
NCT00005106 is a clinical study titled "A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients". The purpose of this study is to look at the effects of different anti-HIV drug combinations on body fat changes in HIV-positive patients who have never received anti-HIV therapy before.
What is the current status of trial NCT00005106?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 230 participants. The study started on 1999-09.
What conditions does trial NCT00005106 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT00005106?
The interventions under investigation include: Lamivudine (DRUG), Stavudine (DRUG), Nelfinavir mesylate (DRUG), Lamivudine/Zidovudine (DRUG), Abacavir sulfate (DRUG).
Who is sponsoring clinical trial NCT00005106?
This trial is sponsored by Glaxo Wellcome, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00005106 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00005106's enrollment target sits among peer trials
230 154th of 542 higher than 388 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Accelerated ART Initiation for PWHIV Who Are Out of Care
RECRUITING · Phase 4
-
Vaccine Immunity and Inflammation in the Aging Person Living With HIV
RECRUITING · Phase 4
-
PrEP Intervention for People Who Inject Substances and Use Methamphetamine
RECRUITING · Phase 4
-
Boosted Atazanavir and Truvada Given Once-Daily - BATON Study
COMPLETED · Phase 4
-
"The Once A Day Protease Inhibitor Regimens"
COMPLETED · Phase 4
-
Buprenorphine and Integrated HIV Care
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia